Abstract Number:
2582
Submission Type:
Contributed Abstract
Contributed Abstract Type:
Speed
Participants:
Archie Sachdeva (1), Ram Tiwari (1)
Institutions:
(1) Bristol Myers Squibb, N/A
Co-Author:
First Author:
Presenting Author:
Abstract Text:
Predictive probability of success, or PPoS, is a crucial decision-making tool that predicts trial success and is computed at various phases of the drug development process. We propose a Dirichlet Process meta-analytic prior (DP-MAP), a non-parametric approach to account for the statistical heterogeneity among the treatment effects across all the historical studies considered for constructing an informative prior, for calculating PPoS. It allows for a more robust inference in the case of prior-data conflict. As the basic premise is to borrow only if the historical information is relevant, some prior trials may concur with or disagree with the current data. DP provides a flexible solution; that is, DP offers the chance to borrow from earlier trials based on their similarity with the current trial and resolves the prior data conflict.
In this paper, we assess the model fit of DP-MAP prior and compare it with the model fit for both the standard meta-analytic predictive prior (MAP) and robust-meta-analytic prior (rMAP) approaches. We utilize a real data example from historical RRMM trials and demonstrate PPoS calculations at the design stage and interim analysis of the ongoing trial.
Keywords:
Dirichlet process prior|Predictive probability of success|interim analysis|clinical trials|Bayesian statistics|go-no go decision
Sponsors:
Biopharmaceutical Section
Tracks:
Clinical Trial Design
Can this be considered for alternate subtype?
Yes
Are you interested in volunteering to serve as a session chair?
Yes
I have read and understand that JSM participants must abide by the Participant Guidelines.
Yes
I understand that JSM participants must register and pay the appropriate registration fee by June 1, 2024. The registration fee is non-refundable.
I understand